5Y & Qiming Back Antibody Design Platform
11 Nov 2025
US$ 20.00
5Y Capital and Qiming Venture Partners have co-led the series A funding round of Aureka Biotechnologies Inc ......
Related Publications
Subscribers’ Weekly...
Hostplus and IP Group Australia have co-led the A$29 m (US$19 m) series A round of RAGE Biotech Pty Ltd (Rage Biotech),...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.